Neurobiology of ammonia

Progress in Neurobiology

Volumn 67, Issue 4, 2002, Pages 259-279

  Felipo, Vicente ^a   Butterworth, Roger F ^b  

^a CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 5 HYDROXYINDOLEACETIC ACID; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMMONIA; BENZODIAZEPINE RECEPTOR; BENZOIC ACID; CARBAMATE KINASE; CARRIER PROTEIN; CYCLIC GMP; DIZOCILPINE; EXCITATORY AMINO ACID TRANSPORTER; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE TRANSPORTER 1; GLUTAMATE AMMONIA LIGASE; GLUTAMATE TRANSPORTER; GLUTAMINASE; GLYCINE TRANSPORTER; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; ORNITHINE ASPARTATE; POSTSYNAPTIC RECEPTOR; QUINOLINIC ACID; SEROTONIN; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE; ASTROCYTOSIS; BRAIN BLOOD FLOW; BRAIN DEVELOPMENT; BRAIN DYSFUNCTION; BRAIN EDEMA; BRAIN FUNCTION; BRAIN LEVEL; BRAIN METABOLISM; BRAIN MITOCHONDRION; CELL STRUCTURE; COMA; CONVULSION; DRUG EFFECT; ENERGY METABOLISM; GABAERGIC SYSTEM; GENE MUTATION; HUMAN; HYPERAMMONEMIA; NEUROBIOLOGY; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; SYNTHESIS; UREA CYCLE;

EID: 0036629585     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(02)00019-9     Document Type: Review

References (192)

1. Aggarwal S., Kramer D., Yonas H. Cerebral hemodynamic and metabolic changes in fulminant hepatic failure: a retrospective study. Hepatology. 19:1994;80-87.
2. Alger B.E., Nicoll R.A. Ammonia does not selectively block IPSPs in rat hippocampal cells. J. Neurophysiol. 59:1983;1381-1392.
3. Baraldi M., Zeneroli M.L., Ventura E., Penne A., Pinelli G., Ricci P., Santi M. Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: reversal by a benzodiazepine antagonist. Clin. Sci. 67:1984;167-175.
4. Basile, A.S., 2002. Direct and indirect enhancement of GABAergic neurotransmission by ammonia: Implications for the pathogenesis of hyperammonemic syndromes. Neurochem. Int. 41 (2-3), 115-122.
5. Batshaw M.L., Brusilow S.W. Treatment of hyperammonemic coma caused by inborn errors of urea synthesis. J. Pediatr. 97:1980;893-900.
6. Batshaw M.L., Hyman S.L., Mellits E.D., Thomas G.H., DeMuro R., Coyle J.T. Behavioral and neurotransmitter changes in the urease-infused rat: a model of congenital hyperammonemia. Pediatr. Res. 20:1986;1310-1315.
7. Batshaw M.L., Heyes M., Djali S., Roke L., Robinson M.B. Tryptophan (Trp), quinolinate (QUIN) and serotonin (5-HT). 1. Alterations in children with hyperammonemia (HA). Soc. Neurosci. Abstr. 323:1990;1.
8. Bélanger M., Ahboucha S., Rocheleau B., Lozeva V., Desjardins P., Huet P.-M., Dodd P.R., Butterworth R.F. Increased expression of peripheral-type benzodiazepine receptors in brain predicts astrocytic pathology and the degree of portal-systemic shunting in chronic liver failure. Hepatology. 34(344A):2001;690.
9. Bélanger, M., Desjardins, P., Chatauret, N., Butterworth, R.F., 2002. Loss of expression of glial fibrillary acidic protein in acute hyperammonemia. Neurochem. Int. 41 (2-3), 155-160.
10. Bender A.S., Hertz L. Pharmacological characteristics of diazepam receptors in neurons and astrocytes in primary cultures. J. Neurosci. Res. 18:1987;366-372.
11. Bergeron M., Reader T.A., Pomier Layrargues G., Butterworth R.F. Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Neurochem. Res. 14:1989;853-859.
12. Bosman D.K., Deutz N.E.P., Maas M.A.W., van Eijk H.M.H., Smit J.J.H., de Haan J.G., Chamuleau A.F.M. Amino acid release from cerebral cortex in experimental acute liver failure, studied by in vivo cerebral corrtex microdialysis. J. Neurochem. 59:1992;591-599.
13. 3-system. J. Clin. Invest. 39:1960;332-341.
14. Butterworth, R.F., 2002. Glutamate transporters in hyperammonemia. Neurochem. Int. 41 (2-3), 81-85.
15. Butterworth R.F., Giguère J.-F. Cerebral amino acids in portal-systemic encephalopathy: lack of evidence for altered GABA function. Metab. Brain Dis. 1:1986;221-228.
16. 3H ]muscimol (GABA-A) binding sites and of central benzodiazepine receptors are unchanged in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy Hepatology. 8:1988;1084-1088.
17. 11C ]R-PK11195 positron emission tomography study J. Hepatol. 34:2001;58. (Abstract).
18. Chan H., Butterworth R.F. Evidence for an astrocytic glutamate transporter deficit in hepatic encephalopathy. Neurochem. Res. 24:1999;1397-1401.
19. Chan H., Hazell A.S., Desjardins P., Butterworth R.F. Effects of ammonia on glutamate transporter (GLAST) protein and mRNA in cultured rat cortical astrocytes. Neurochem. Int. 37:2000;243-248.
20. Chatauret N., Rose C., Therrien G., Butterworth R.F. Mild hypothermia prevents cerebral edema and CSF lactate accumulation in acute liver failure. Metab. Brain Dis. 16:2001;95-102.
21. Clemmensen J.O., Larsen F.S., Kondrup J., Hansen B.A., Ott P. Cerebral herniation in patients with acute liver is correlated with arterial ammonia concentration. Hepatology. 29:1999;648-653.
22. Colombo J.P., Bachmann C., Peheim E., Beruter J. Enzymes of ammonia detoxication after portacaval shunt in the rat. II. Enzymes of glutamate metabolism. Enzyme. 22:1977;399-406.
23. Cooper A.J.L., Plum P. Biochemistry and physiology of brain ammonia. Physiol. Rev. 67:1987;40-519.
24. 13N -labeled ammonia in rat brain J. Biol. Chem. 254:1979;4982-4992.
25. Cooper A.J.L., Mora S.N., Cruz N.F., Gelbard A.S. Cerebral ammonia metabolism in hyperammonemic rats. J. Neurochem. 44:1985;1716-1723.
26. Cordoba J., Blei A.T. Treatment of hepatic encephalopathy. Am. J. Gastroenterol. 92:1997;1429-1439.
27. Cremer J.E., Heath D.F., Teal H.M., Woods M.S., Cavanagh J.B. Some dynamic aspects of brain metabolism in rats given a portacaval anastomosis. Neuropathol. Appl. Neurobiol. 3:1975;293-311.
28. De Knegt R.J., Schalm S.W., van der Rijt C.C.D., Fekkes D., Dalm E., Hekking-Weyma I. Extracellular brain glutamate during acute liver failure and during acute hyperammonemia simulating acute liver failure. J. Hepatol. 20:1994;19-26.
29. Desjardins, P., Butterworth, R.F., 2002. The "peripheral-type" benzodiazepine (omega 3) receptor in hyperammonemic disorders. Neurochem. Int. 41 (2-3), 109-114.
30. Desjardins P., Bandeira P., Raghavendra Rao V.L., Ledoux S., Butterworth R.F. Increased expression of the peripheral-type benzodiazepine receptor-isoquinoline carboxamide binding protein in brain following portacaval anastomosis. Brain Res. 758:1997;255-258.
31. Desjardins P., Michalak A., Therrien G., Chatauret N., Butterworth R.F. Increased expression of the astrocytic/endothelial cell glucose transporter (and water channel) protein GLUT-1 in relation to brain glucose metabolism and edema in acute liver failure. Hepatology. 34(237A):2001;253.
32. Dodd P.R., Thomas G.J., Harper C.G., Kril J.J. Amino acid neurotransmitter receptor changes in cerebral cortex in alcoholism: effects of cirrhosis of the liver. J. Neurochem. 59:1992;1506-1515.
33. Dolman C.L., Clasen R.A., Dorovini-Zis K. Severe cerebral damage in ornithine transcarbamylase deficiency. Clin. Neuropathol. 7:1988;10-15.
34. Eng L.F. Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J. Neuroimmunol. 9:1985;203-214.
35. Erecinska M., Pastuszko A., Wilson D.F., Nelson D. Ammonia-induced release of neurotransmitters from rat brain synaptosomes: differences between the effects on amines and amino acids. J. Neurochem. 49:1987;1258-1265.
36. Fan P., Szerb J.C. Effects of ammonium ions on synaptic transmission and on responses to quisqualate and N-methyl-D-aspartate in hippocampal CA1 pyramidal neurons in vitro. Brain Res. 632:1993;225-231.
37. Fan P., Lavoie J., Le N.L.O., Szerb J.C., Butterworth R.F. Neurochemical and electrophysiological studies on the inhibitory effect of ammonium ions on synaptic transmission in slices of rat hippocampus: evidence for a postsynaptic action. Neuroscience. 37:1990;327-334.
38. Filloux F., Townsend J.J., Leonard C. Ornithine transcarbamylase deficiency: neuropathologic changes acquired in utero. J. Pediatr. 108:1986;942-945.
39. Giguère J.-F., Butterworth R.F. Amino acid changes in regions of the CNS in relation to function in experimental portal-systemic encephalopathy. Neurochem. Res. 9:1984;1309-1321.
40. 3H ]PK11195 in rat brain following portacaval anastomosis Brain Res. 585:1992;295-298.
41. Girard, G., Giguère, J.-F., Butterworth, R.F., 1989. Effect of portacaval anastomosis on ammonia metabolism in brain and liver. In: Butterworth, R.F., Pomier Layrargues, G. (Eds.), Hepatic Encephalopathy: Pathophysiology and Treatment. Humana Press, Clifton, NJ, pp. 79-89.
42. Girard G., Giguère J.-F., Butterworth R.F. Region-selective reductions in activities of glutamine synthetase in rat brain following portacaval anastomosis. Metab. Brain Dis. 8:1993;207-215.
43. Grau E., Marcaida G., Montoliu C., Miñana M.D., Grisolia S., Felipo V. Effects of hyperammonemia on brain protein kinase C substrates. Metab. Brain Dis. 11:1996;205-216.
44. Gregorios J.B., Mozes L.W., Norenberg L.O., Norenberg M.D. Morphologic effects of ammonia on primary astrocyte cultures. I. Light microscopic studies. J. Neuropathol. Exp. Neurol. 44:1985;397-403.
45. Grippon P., Le Poncin Lafitte M., Boschat M., Wang S., Faure G., Dutertre D., Opolon P. Evidence for the role of ammonia in the intracerebral transfer and metabolism of tryptophan. Hepatology. 6:1986;682-686.
46. A receptor complex by ammonia: implications for the pathogenesis of hyperammonemic syndromes. Brain Res. 720:1996;35-44.
47. Hamberger A., Nyström B. Extra- and intracellular amino acids in the hippocampus during development of hepatic encephalopathy. Neurochem. Res. 9:1984;1181-1192.
48. Hamberger A., Lindroth P., Nyström B. Regulation of glutamate biosynthesis and release in vitro by low levels of ammonium ions. Brain Res. 237:1982;339-350.
49. Harding B.N., Leonard J.V., Erdohazi M. Ornithine transcarbamylase deficiency: neuropathological study. Eur. J. Pediatr. 141:1984;215.
50. Harper, C.G., Butterworth, R.F., 1997. Nutritional and metabolic disorders. In: Graham, D.I., Lantos, P.L. (Eds.), Greenfield's Neuropathology. Arnold, London, UK, pp. 601-655.
51. Haussinger D. Hepatocyte heterogeneity in glutamine and ammonia metabolism and the role of an intercellular glutamine cycle during ureogenesis in perfused rat liver. Eur. J. Biochem. 133:1983;269-275.
52. Haussinger D., Gerok W. Regulation of hepatic glutamate metabolism. Role of 2-oxoacids in glutamate release from isolated perfused rat liver. Eur. J. Biochem. 143:1984;491-497.
53. Hawkins R.A., Miller A.L., Nielsen R.C., Veech R.L. The acute action of ammonia on rat brain metabolism in vivo. Biochem. J. 134:1973;1001-1008.
54. Hazell A.S., Butterworth R.F. Hepatic encephalopathy: an update of pathophysiologic mechanisms. Proc. Soc. Exp. Biol. Med. 222:1999;99-112.
55. Hermenegildo C., Marcaida G., Montoliu C., Grisolia S., Miñana M.D., Felipo V. NMDA receptor antagonists prevent acute ammonia toxicity in mice. Neurochem. Res. 21:1996;1237-1244.
56. Hermenegildo C., Montoliu C., Llansola M., Munoz M.D., Gaztelu J.M., Miñana M.D., Felipo V. Chronic hyperammonemia impairs the glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in the rat in vivo. Eur. J. Neurosci. 10:1998;3201-3209.
57. Hermenegildo C., Monfort P., Felipo V. Activation of NMDA receptors in rat brain in vivo following acute ammonia intoxication. Characterization by in vivo brain microdialysis. Hepatology. 31:2000;709-715.
58. Hilgier W., Zielinska M., Borkowska H.D., Gadamski R., Saransaari P., Albrecht J. Changes in extracellular profiles of neuroactive amino acids in rat striatum at the asymptomatic stage of hepatic encephalopathy. J. Neurosci. Res. 56:1999;76-84.
59. Hindfelt B., Siesjo B.K. Cerebral effects of acute ammonia intoxication. II. The effect upon energy metabolism. Scand. J. Clin. Lab. Invest. 28:1971;365-374.
60. Hindfelt B., Plum F., Duffy T.E. Effect of acute ammonia intoxication on cerebral metabolism in rats with portacaval shunts. J. Clin. Invest. 59:1977;386-396.
61. Hopkins K.J., Oster-Granite M.L. Characterization of N-methyl-D-aspartate receptors in the hyperammonemic sparse fur mouse. Brain Res. 797:1998;209-217.
62. 3H ]-PK11195 Neurosci. Lett. 177:1994;35-38.
63. Itzhak Y., Roig-Cantisano A., Dombro R.S., Norenberg M.D. Acute liver failure and hyperammonemia increase peripheral-type benzodiazepine receptor binding and pregnenolone synthesis in mouse brain. Brain Res. 705:1995;345-348.
64. James I.M., Garassini M. Effect of lactulose on cerebral metabolism in patients with chronic portosystemic encephalopathy. Gut. 12:1971;702-704.
65. James I.M., MacDonnell L., Xanalatos C. The effect of acute portacaval shunting in dogs on cerebral and peripheral blood flow and metabolism. Clin. Sci. 42:1972;769-774.
66. James I.M., MacDonnell I., Xanalatos C. Effect of ammonium salts on brain metabolism. J. Neurol. Neurosurg. Psychiatry. 37:1974;948-953.
67. Jellinger K., Riederer P., Kleinberger G., Wuketich S., Kothbauer P. Brain monoamines in human hepatic encephalopathy. Acta Neuropathol. 43:1978;63-68.
68. Kato M., Hughes R.D., Keays R.T., Williams R. Electron microscopic study of brain capillaries in cerebral edema from fulminant hepatic failure. Hepatology. 15:1992;1060-1066.
69. Kircheis G., Nilius R., Held C., Berndt H., Buchner M., Gortelmeyer R., Hendricks R., Kruger B., Kuklinski B., Meister H., Otto H.J., Rink C., Rosch W., Stauch S. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study. Hepatology. 25:1997;1351-1360.
70. Knecht K., Michalak A., Rose C., Rothstein J.D., Butterworth R.F. Decreased glutamate transporter (GLT-1) expression in frontal cortex of rats with acute liver failure. Neurosci. Lett. 229:1997;201-203.
71. Knell A.J., Davidson A.R., Williams R., Kantamaneni B.D., Curzon G. Dopamine- and serotonin metabolism in hepatic encephalopathy. Br. Med. J. 1:1974;549-551.
72. Kosenko E., Kaminsky Y.G., Felip V., Miñana M.D., Grisolia S. Chronic hyperammonemia prevents changes in brain energy and ammonia metabolites induced by acute ammonium intoxication. Biochim. Biophys. Acta. 1180:1993;321-326.
73. +-ATPase. J. Neurochem. 63:1994;2172-2178.
74. Kosenko E., Kaminsky Y., Grau E., Miñana M.D., Grisolia S., Felipo V. Nitroarginine, an inhibitor of nitric oxide synthetase, attenuates ammonia toxicity and ammonia-induced alterations in brain metabolism. Neurochem. Res. 20:1995;451-456.
75. Kosenko E., Kaminsky Y., Kaminsky A., Valencia M., Lee L., Hermenegildo C., Felipo V. Superoxide production and antioxidant enzymes in ammonia intoxication in rats. Free Rad. Res. 27:1997;637-644.
76. Kosenko E., Kaminsky Y., Lopata O., Muravyov N., Kaminsky A., Hermenegildo C., Felipo V. Nitroarginine, an inhibitor of nitric oxide synthase, prevents changes in superoxide radical and antioxidant enzymes induced by ammonia intoxication. Metab. Brain Dis. 13:1998;29-41.
77. Kosenko E.L., Kaminsky Y., Lopata O., Muravyov N., Felipo V. Blocking NMDA receptors prevents the oxidative stress induced by acute ammonia intoxication. Free Rad. Biol. Med. 26:1999;1369-1374.
78. Kosenko E., Kaminsky Y., Stavroskaya I.G., Felipo V. Alteration of mitochondrial calcium homeostasis by ammonia-induced activation of NMDA receptors in rat brain in vivo. Brain Res. 880:2000;139-146.
79. Kril J.J., Flowers D., Butterworth R.F. Distinctive pattern of Bergmann glial pathology in human hepatic encephalopathy. Mol. Chem. Neuropathol. 31:1997;279-287.
80. Krueger K.E., Papadopoulos V. Mitochondrial benzodiazepine receptors and the regulation of steroid biosynthesis. Ann. Rev. Pharmacol. Toxicol. 32:1992;211-237.
81. Lai J.C.K., Cooper A.J.L. Brain ∀-ketoglutarate dehydrogenase complex: kinetic properties, regional distribution and effects of inhibitors. J. Neurochem. 47:1986;1376-1386.
82. Larsen F.S. Cerebral circulation in liver failure: Ohm's law in force. Semin. Liver Dis. 16:1996;281-292.
83. Laubenberger J., Haussinger D., Bayer S., Gufler H., Hennig J., Langer M. Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis. Gastroenterology. 112:1997;1758-1761.
84. Lavoie J., Giguère J.-F., Pomier Layrargues G., Butterworth R.F.et al. Activities of neuronal and astrocytic marker enzymes in autopsied brain tissue from patients with hepatic encephalopathy. Metab. Brain Dis. 2:1987a;283-290.
85. Lavoie J., Giguère J.-F., Pomier Layrargues G., Butterworth R.F. Amino acid changes in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. J. Neurochem. 49:1987;692-697.
86. Lavoie J., Pomier Layrargues G., Butterworth R.F. Increased densities of peripheral-type benzodiazepine receptors in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Hepatology. 11:1990;874-878.
87. Lockwood A.H., Ginsberg M.D., Butler C.M., Gutierrez M.T. Selective effects of ammonia on regional brain glucose metabolism. Ann. Neurol. 12:1982;114.
88. Lockwood A.H., Yap E.W., Wong W.H. Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J. Cereb. Blood Flow Metab. 11:1991;337-341.
89. Lockwood A.H., Murphy B.W., Donnelly K.Z., Mahl T.C., Perini S. Positron-emission tomographic localization of abnormalities of brain metabolism in patients with minimal hepatic encephalopathy. Hepatology. 18:1993;1061-1068.
90. Lockwood A., Weissenborn K., Butterworth R.F. An image of the brain in patients with liver disease. Curr. Opin. Neurol. 10:1997;525-533.
91. Lombardi G., Mannaioni G., Leonadi P., Cherici G., Carla V., Moroni F. Ammonium acetate inhibits ionotropic receptors and differentially affects metabotropic receptors for glutamate. J. Neural Transm. 97:1994;187-196.
92. Lozeva V., Montgomery J.A., Rocheleau B., Tuomisto L., Huet P.-M., Butterworth R.F. Selective alterations of central serotoninergic and histaminergic function following graded portal-systemic shunts: implications for the pathogenesis of post-TIPS encephalopathy. Hepatology. 34(185A):2001;45.
93. Lux H.D. Ammonia and chloride extrusion: hyperpolarizing synaptic inhibition in cat spinal motoneurons. Science. 193:1971;555-557.
94. Maddison J.E., Dodd P.R., Morrison M.et al. Plasma GABA, GABA-like activity and the brain GABA-benzodiazepine receptor complex in rats with chronic hepatic encephalopathy. Hepatology. 7:1987a;621-628.
95. Maddison J.E., Dodd P.R., Johnston G.A.R.et al. Brain GABA receptor binding is normal in rats with thioacetamide-induced hepatic encephalopathy despite elevated plasma GABA-like activity. Gastroenterology. 93:1987;1062-1068.
96. Mans A.M., DeJoseph M.R., Hawkins R.A. Metabolic abnormalities and grade of encephalopathy in acute hepatic failure. J. Neurochem. 63:1994;1829-1838.
97. Marcaida G., Felipo V., Hermenegildo C., Miñana M.D., Grisolia S. Acute ammonia toxicity is mediated by NMDA type of glutamate receptors. FEBS Lett. 296:1992;67-68.
98. Marcaida G., Miñana M.D., Burgal M., Grisolia S., Felipo V. Ammonia prevents activation of NMDA receptors by glutamate in rat cerebellar neuronal cultures. Eur. J. Neurosci. 7:1995;2389-2396.
99. Margulies J.E., Thompson R.C., Demetriou A.A. Aquaporin-4 water channel is up-regulated in the brain in fulminant hepatic failure. Hepatology. 30:1999;395A. (Abstract).
100. McArdle P., Penning D.H., Dexter F., Reynolds J.D. Flumazenil does not affect the increase in rat hippocampal extracellular glutamate concentration produced during thioacetamide-induced hepatic encephalopathy. Metab. Brain Dis. 11:1996;329-342.
101. McCandless D.W., Schenker S. Effect of acute ammonia intoxication on energy stores in the cerebral reticular activating system. Exp. Brain Res. 44:1981;325-330.
102. McEnery M.W., Snowman A.M., Trifiletti R.R., Snyder S.H. Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc. Natl. Acad. Sci. U.S.A. 89:1992;3170-3174.
103. McKhann G.M., Tower D.B. Ammonia toxicity and cerebral oxidative metabolism. Am. J. Med. 200:1961;420.
104. Mena E.E., Cotman C.W. Pathologic concentrations of ammonium ions block L-glutamate uptake. Exp. Neurol. 89:1985;259-263.
105. Michalak A., Butterworth R.F. Ornithine transcarbamylase deficiency: pathophysiologic mechanisms and new prospects for therapy. Metab. Brain Dis. 12:1997a;163-174.
106. Michalak A., Butterworth R.F. Ornithine transcarbamylase deficiency: pathogenesis of the cerebral disorder and new prospects for therapy. Metab. Brain Dis. 12:1997b;171-182.
107. Michalak A., Rose C., Butterworth J., Butterworth R.F. Neuroactive amino acids and glutamate (NMDA) receptors in frontal cortex of rats with experimental acute liver failure. Hepatology. 24:1996;908-913.
108. Michalak A., Rose C., Buu P.N.T., Butterworth R.F. Evidence for altered central noradrenergic activity in experimental acute liver failure. Hepatology. 27:1998;362-368.
109. Miñana M.D., Kosenko E., Marcaida G., Hermenegildo C., Montoliu C., Grisolia S., Felipo V. Modulation of glutamine synthesis in cultured astrocytes by nitric oxide. Cell. Mol. Neurobiol. 17:1997;433-445.
110. Montfort, P., Kosenko, E., Erceg, S., Canales, J.-J., Felipo, V., in press. Molecular mechanism of acute ammonia toxicity: role of NMDA receptors. Neurochem. Int.
111. Morgan M.Y., Jakobovits A.W., James I.M.et al. Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy. Gastroenterology. 78:1980;663-670.
112. Moroni F., Lombardi G., Moneti G., Cortesini C. The release and the neosynthesis of glutamic acid are increased in experimental models of hepatic encephalopathy. J. Neurochem. 40:1983;850-854.
113. Moroni F., Lombardi G., Carla V., Lal S., Etienne P., Nair N.P.V. Increase in the content of quinolinic acid in cerebrospinal fluid and frontal cortex of patients with hepatic failure. J. Neurochem. 47:1986;1667-1671.
114. Mousseau D.D., Baker G.B., Butterworth R.F. Increased density of catalytic sites and expression of brain monoamine oxidase A in humans with hepatic encephalopathy. J. Neurochem. 68:1997;1200-1208.
115. Msall M., Batshaw M.L., Suss R., Brusilow S.W., Mellits E.D. Neurologic outcome in children with inborn errors of urea synthesis. N. Engl. J. Med. 310:1984;1500-1505.
116. Mullen K.D., Jones E.A. Natural benzodiazepines and hepatic encephalopathy. Semin. Liver Dis. 16:1996;255-264.
117. Neary J.T., Whittemore S.R., Zhu Q., Norenberg M.D. Destabilisation of glial fibrillary acidic protein mRNA in astrocytes by ammonia and protection by extracellular ATP. J. Neurochem. 63:1994;2021-2027.
118. Norenberg M.D. A light and electron microscopic study of experimental portal-systemic (ammonia) encephalopathy. Lab. Invest. 36:1977;618-627.
119. Norenberg M.D. The astrocyte in liver disease. Adv. Cell Neurobiol. 2:1981;303-352.
120. Norenberg M.D. The role of astrocytes in hepatic encephalopathy. Neurochem. Pathol. 6:1987;13-33.
121. Norenberg M.D., Lapham L.W. The astrocyte response in experimental portal-systemic encephalopathy: an electron microscopic study. J. Neuropathol. Exp. Neurol. 33:1974;422-435.
122. Norenberg M.D., Martinez-Hernandez A. Fine structural localization of glutamine synthetase in astrocytes of rat brain. Brain Res. 161:1979;120-303.
123. Norenberg M.D., Huo Z., Neary J.T., Roig-Cantisano A. The glial glutamate transporter in hyperammonemia and hepatic encephalopathy: relation to energy metabolism and glutamatergic neurotransmission. Glia. 21:1997;124-133.
124. O'Carroll R.E., Hayes P.C., Ebmeier K.P.et al. Regional cerebral blood flow and cognitive function in patients with chronic liver disease. Lancet. 337:1991;1250-1253.
125. Olasmaa M., Rothstein J.D., Guidotti A., Weber R.J., Paul S.M., Spector S., Baraldi M., Costa E. Endogenous benzodiazepine receptor ligands in human and animal hepatic encephalopathy. J. Neurochem. 55:1990;2015-2033.
126. Oppong K.N.W., Bartlett K., Record C.O., Mardini H. Synaptosomal glutamate transport in thioacetamide-induced hepatic encephalopathy in the rat. Hepatology. 22:1995;553-558.
127. Perney P., Butterworth R.F., Mousseau D.D., Lavoie J., Fabbro-Peray P., Blanc F., Pomier Layrargues G. Plasma and CSF benzodiazepine receptor ligand concentrations in cirrhotic patients with hepatic encephalopathy: relationship to severity of encephalopathy and to pharmaceutical benzodiazepine intake. Metab. Brain Dis. 12:1998;201-210.
128. 3H -sensitive-glutamate binding sites in rat brain following portacaval anastomosis J. Neurochem. 55:1990;386-390.
129. 3 Stroke. 8:1977;694-702.
130. Pomier Layrargues G., Giguère J.-F., Lavoie J., Perney P., Gagnon S., D'Amour M., Wells J., Butterworth R.F. Clinical efficacy of benzodiazepine antagonist RO 15-1788 (flumazenil) in cirrhotic patients with hepatic coma: results of a randomized double-blind placebo-controlled cross-over trial. Hepatology. 19:1994;32-37.
131. Pomier Layrargues G., Spahr L., Butterworth R.F. Increased manganese concentrations in pallidum of cirrhotic patients: cause of magnetic resonance hyperintensity? Lancet. 345:1995;735.
132. Posner J.B., Plum F. The toxic effect of carbon dioxide and acetazolamide in hepatic encephalopathy. J. Clin. Invest. 39:1960;1246-1258.
133. Prior, R.L., Visek, W.J., 1972. Effects of urea hydrolysis on tissue metabolite concentrations in rats. Am. J. Physiol., 1143-1149.
134. Raabe, W., 1987. Neurophysiology of ammonia intoxication. In: Butterworth, R.F., Pomier Layrargues, G. (Eds.), Hepatic Encephalopathy: Pathophysiology and Treatment. Humana Press, Clifton, NJ, pp. 49-77.
135. + on reflexes in cat spinal cord. J. Neurophysiol. 64:1990;565-574.
136. Raabe W., Lin S. Pathophysiology of ammonia intoxication. Exp. Neurol. 87:1983;519-532.
137. 13N -ammonia from blood to brain Circ. Res. 48:1981;913-937.
138. Rao K.V.R., Qureshi I.A. Reduction in MK-801 binding sites of the NMDA sub-type of glutamate receptor in a mouse model of congenital hyperammonemia: prevention by acetyl-L-carnitine. Neuropharmacology. 38:1999;383-394.
139. Rao V.L.R., Agrawal A.K., Murthy C.R. Ammonia-induced alterations in glutamate and muscimol binding to cerebellar synaptic membranes. Neurosci. Lett. 130:1991;251-254.
140. 3H ]PK11195 in congenital ornithine transcarbamylase deficient sparse-fur mouse Pediatr. Res. 34:1993a;777-778.
141. B in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Brain Res. 621:1993;349-352.
142. 3H ]arginine uptake in brain following portacaval anastomosis J. Neurochem. 65:1995;677-678.
143. 3H ]nitroarginine into rat brain synaptosomes J. Neurochem. 68:1997;337-343.
144. Ratnakumari L., Qureshi I.A., Butterworth R.F. Effects of congenital hyperammonemia on the cerebral and hepatic levels of the intermediates of energy metabolism in spf mice. Biochem. Biophys. Res. Commun. 184:1992;746-751.
145. Ratnakumari L., Qureshi I.A., Butterworth R.F. Regional amino acid neurotransmitter changes in brains of spf/Y mice with congenital ornithine transcarbamylase deficiency. Metab. Brain Dis. 9:1994;43-51.
146. 3H ]MK801 binding sites in brain in congenital ornithine transcarbamylase deficiency Metab. Brain Dis. 10:1995;249-255.
147. Robinson M.B., Hopkins K., Batshaw M.L., McLaughlin B.A., Heyes M.P., Oster-Granite M.L. Evidence of excitotoxicity in the brain of the ornithine carbamoyltransferase deficient sparse fur mouse. Dev. Brain Res. 90:1985;35-44.
148. 1A receptors are altered in the congenitally hyperammonemic sparse fur mouse. J. Neurochem. 58:1992;1016-1022.
149. Robinson M.B., Hopkins K., Batshaw M.L., McLaughlin B.A., Heyes M.P., Oster-Granite M.L. Evidence of excitotoxicity in the brain of the ornithine carbamoyltransferase deficient sparse fur mouse. Dev. Brain Res. 90:1995;35-44.
150. Rose C., Michalak A., Pannunzio P., Therrien G., Quack G., Kircheis G., Butterworth R.F. Orthinine-L-aspartate in experimental portal-systemic encephalopathy: therapeutic efficacy and mechanism of action. Metab. Brain Dis. 13:1998;147-157.
151. Rose C., Michalak A., Rama Rao K.V., Quack G., Kircheis G., Butterworth R.F. L-Ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure. Hepatology. 30:1999;636-640.
152. Rose C., Michalak A., Pannunzio M., Chatauret N., Rambaldi A., Butterworth R.F. Mild hypothermia delays the onset of coma and prevents brain edema and extracellular brain glutamate accumulation in rats with acute liver failure. Hepatology. 31:2000;872-877.
153. Roy S., Pomier Layrargues G., Butterworth R.F., Huet P.-M. Hepatic encephalopathy in cirrhotic and portocaval shunted dogs: lack of changes in brain GABA uptake. Hepatology. 8:1988;845-849.
154. Saez R., Llansola M., Felipo V. Chronic exposure to ammonia alters pathways modulating phosphorylation of microtubule-associated protein 2 in cerebellar neurons in culture. J. Neurochem. 73:1999;2555-2562.
155. Saransaari P., Oja S.S., Borkowska H.D., Koistinaho J., Hilgier W., Albrecht J. Effects of thioacetamide-induced hepatic failure on the N-methyl-D-aspartate receptor complex in the rat cerebral cortex, striatum and hippocampus. Mol. Chem. Neuropathol. 32:1997;179-193.
156. Schafer D.F., Jones E.A. Hepatic encephalopathy and the γ-aminobutyric acid neurotransmitter system. Lancet. 1:1982;18-29.
157. Schafer D.F., Fowler J.M., Munson P.J., Thakur A.K., Waggoner J.G., Jones E.A. Gamma-aminobutyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure. J. Lab. Clin. Med. 102:1983;870-880.
158. Schenker S., McCandless D.W., Brophy E., Lewis M.S. Studies on the intracerebral toxicity of ammonia. J. Clin. Invest. 46:1967;838-848.
159. Schmidt W., Wolf G., Grungreiff K., Meier M., Reum T. Hepatic encephalopathy influences high-affinity uptake of transmitter glutamate and aspartate into the hippocampal formation. Metab. Brain Dis. 5:1990;19-31.
160. Schultz V., Lowenstein J.M. The purine nucleotide cycle. Studies of ammonia production and interconversions of adenine and hypoxanthine nucleotides and nucleosides by rat brain in situ. J. Biol. Chem. 253:1978;1938-1943.
161. Shiraishi T., Black K.L., Ikezaki K., Becker D.P. Peripheral benzodiazepine induces morphological changes and proliferation of mitochondria in glioma cells. J. Neurosci. Res. 30:1991;463-474.
162. Sobel R.A., DeArmond S.J., Forno L.S., Eng L.F. Glial fibrillary acid protein in hepatic encephalopathy. An immunohistochemical study. J. Neuropathol. Exp. Neurol. 40:1981;625-632.
163. Sugden P.H., Newsholme E.A. The effects of ammonium, inorganic phosphate and potassium ions on the activity of phosphofructokinases from muscle and nervous tissue of vertebrates and invertebrates. Biochem. J. 150:1975;113-122.
164. Sushma S., Dasarathy S., Tandon R.K.et al. Sodium benzoate in the treatment of acute hepatic encephalopathy: a double-blind randomized trial. Hepatology. 16:1992;138-144.
165. Suzuki K., Matsuo N., Moriguchi T., Takeyama N., Kitazawa Y., Tanaka T. Changes in brain ECF amino acids in rats with experimentally induced hyperammonemia. Metab. Brain Dis. 7:1992;63-75.
166. Swain M., Butterworth R.F., Blei A.T. Ammonia and related amino acids in the pathogenesis of brain edema in acute ischemic liver failure in rats. Hepatology. 15:1992a;449-453.
167. Swain M., Bergeron M., Audet R., Blei A.T., Butterworth R.F. Monitoring of neurotransmitter amino acids by means an indwelling cisterna magna catheter: a comparison of two rodent models of fulminant hepatic failure. Hepatology. 16:1992;1028-1035.
168. Szerb J.C., Butterworth R.F. Effect of ammonium ions on synaptic transmission in the mammalian central nervous system. Prog. Neurobiol. 39:1992;135-153.
169. 2 responsivity by glutamine synthesis inhibition in hyperammonemic rats. Circ. Res. 71:1992;1220-1230.
170. Takayanagi M., Ohtake A., Ogura N., Nakajima H., Hoshino M. A female case of ornithine transcarbamylase deficiency with marked computed tomographic abnormalities of the brain. Brain Dev. 6:1984;58.
171. 31 magnetic resonance spectroscopy in patients with chronic hepatic encephalopathy. Hepatology. 20:1994;1173-1178.
172. Théoret Y., Bossu J.-L. Effects of ammonium salts on synaptic transmission to hippocampal CA1 and CA3 pyramidal cells in vivo. Neuroscience. 14:1985;807-821.
173. Théoret Y., Davies M.F., Esplin B., Capek R. Effects of ammonium chloride on synaptic transmission in the rat hippocampal slice. Neuroscience. 14:1985;798-806.
174. Therrien G., Giguère J.-F., Butterworth R.F. Increased cerebrospinal fluid lactate reflects deterioration of neurological status in experimental portal-systemic encephalopathy. Metab. Brain Dis. 6:1991;225-231.
175. Tossman U., Eriksson S., Delin A., Hagenfeldt L., Law D., Ungerstedt U. Brain amino acids measured by intracerebral dialysis in portacaval shunted rats. J. Neurochem. 41:1983;1046-1051.
176. Tossman U., Delin A., Eriksson L.S., Ungerstedt U. Brain cortical amino acids measured by intracerebral dialysis in portacaval shunted rats. Neurochem. Res. 12:1987;265-269.
177. Tuchman M., Plante R.J., Garcia-Perez M.A., Rubio V. Relative frequency of mutation causing ornithine transcarbamylase deficiency in 78 families. Hum. Genet. 97:1996;274-276.
178. Tyce G.M., Ogg J., Owen C.A. Metabolism of acetate to amino acids in brains of rats after complete hepatectomy. J. Neurochem. 36:1981;640-650.
179. 14N -ammonium chloride loading. In: Soeters, P.B., Wilson, J.H.P., Meijer, A.J., Holm, E. (Eds.), Advances in Ammonia Metabolism and Hepatic Encephalopathy. Excerta Medica, Amsterdam, pp. 433-438.
180. Victor M., Adams R.A., Cole M. The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration. Medicine. 44:1965;345-396.
181. Vogels B.A., Maas M.A., Daalhuisen J., Quack G., Chamuleau R.A. Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats. Hepatology. 25:1997;820-827.
182. Warren K.S. The differential toxicity of ammonium salts. J. Clin. Invest. 37:1958;497-501.
183. Warren K.S., Schenker S. Hypoxia and ammonia toxicity. Am. J. Physiol. 199:1960;1105.
184. Warren K.S., Schenker S. Effect of an inhibitor of glutamine synthesis (methionine sulfoximine) on ammonia toxicity and metabolism. J. Lab. Clin. Med. 64:1964;442-449.
185. Watanabe A., Takei N., Shiota T., Nakatsukasa H., Fujiwara M., Sakata T., Nagashima H. Glutamic acid and glutamine levels in serum and cerebrospinal fluid in hepatic encephalopathy. Biochem. Med. 32:1984;225-231.
186. Wendon J.A., Harrison P.M., Keays R., Williams R. Cerebral blood flow and metabolism in fulminant liver failure. Hepatology. 19:1994;1407-1413.
187. Yao H., Sodoshima S., Fujii K., Kusada K., Ishitsuka T., Tamaki K., Fujishima M. Cerebrospinal fluid lactate in patients with hepatic encephalopathy. Eur. Neurol. 27:1987;182-187.
188. Young S.N., Lal S. CNS tryptamine metabolism in hepatic coma. J. Neural Transm. 47:1980;153-161.
189. Young S.N., Lal S., Sourkes T.L., Feldmuller F., Aronoff A., Martin J.B. Relationship between tryptophan in serum and CSF and 5-hydroxy-indoleacetic acid in CSF of man: effect of cirrhosis of liver and probenecid administration. J. Neurol. Neurosurg. Psychiatry. 38:1975;322-330.
190. Zamora A.J., Cavanagh J.B., Kyu M.H. Ultrastructural responses of the astrocytes to portocaval anastomosis in the rat. J. Neurol. Sci. 18:1973;25-45.
191. Zieve L., Doizaki W.M., Zieve F. Synergism between mercaptans and ammonia or fatty acids in the production of coma: a possible role for mercaptans in the pathogenesis of hepatic coma. J. Lab. Clin. Med. 83:1974;16-28.
192. Zwingmann C., Desjardins P., Michalak A., Hazell A.S., Chatauret N., Butterworth R.F. Reduced expression of the astrocytic glycine transporter protein Glyt-1 in frontal cortex of rats with acute liver failure. Hepatology. 34(300A):2001;511.